Fulgent Genetics, Inc. Annual Operating Income (Loss) in USD from 2014 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Fulgent Genetics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2014 to 2023.
  • Fulgent Genetics, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$17.1M, a 8081% decline year-over-year.
  • Fulgent Genetics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$209M, a 158% decline year-over-year.
  • Fulgent Genetics, Inc. annual Operating Income (Loss) for 2023 was -$196M, a 210% decline from 2022.
  • Fulgent Genetics, Inc. annual Operating Income (Loss) for 2022 was $179M, a 73.6% decline from 2021.
  • Fulgent Genetics, Inc. annual Operating Income (Loss) for 2021 was $676M, a 133% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$196M -$374M -210% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-28
2022 $179M -$497M -73.6% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-28
2021 $676M +$386M +133% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-28
2020 $290M +$291M Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 -$428K +$4.64M +91.6% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
2018 -$5.07M -$1.59M -45.6% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-13
2017 -$3.48M -$4.4M -479% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-22
2016 $918K +$5.93M Jan 1, 2016 Dec 31, 2016 10-K 2018-03-20
2015 -$5.01M -$4.02M -406% Jan 1, 2015 Dec 31, 2015 10-K 2017-03-17
2014 -$990K Jan 1, 2014 Dec 31, 2014 10-K 2017-03-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.